San Diego, CA, United States of America

Wei Lin

This inventor holds 8 USPTO granted patents and 9 published patent applications. Top assignees: Resq Pharmaceuticals LLC, Texas Instruments Corporation. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Lin. Retrieved from https://idiyas.com/inventor/wei-lin-yozl1uta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2008-2026

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Wei Lin in Edema Treatment

Introduction

Wei Lin is an accomplished inventor based in San Diego, CA, with a notable portfolio of seven patents. His work primarily focuses on innovative methods for treating medical conditions, particularly edema that is resistant to traditional oral diuretics.

Latest Patents

Among his latest patents, Wei Lin has developed methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide. This invention aims to provide effective treatment options for subjects suffering from edema that does not respond to oral diuretics.

Career Highlights

Wei Lin has made significant contributions to the field of pharmaceuticals through his work at Resq Pharmaceuticals LLC and Texas Instruments Corporation. His expertise in developing treatment methods has positioned him as a key figure in medical innovation.

Collaborations

Wei Lin has collaborated with notable professionals in his field, including Balasingam Radhakrishnan and Ben Esque. These partnerships have further enhanced his research and development efforts.

Conclusion

Wei Lin's innovative approaches to treating edema highlight his commitment to advancing medical science. His contributions continue to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…